
PRVA Stock Forecast & Price Target
PRVA Analyst Ratings
Bulls say
Privia Health Group Inc has demonstrated robust growth, achieving a 20% year-over-year increase in MSSP beneficiaries and improving its savings rate by 150 basis points following its strategic acquisition of CMG in Connecticut for approximately $25 million. The company has successfully implemented over 100 providers in the market, indicating its effective execution of Care Partners type deals focused on value-based care economics. Additionally, while Privia aims to expand quickly through partnerships with larger health systems and medical groups, enhancing organic provider growth in existing markets is a critical milestone for achieving long-term targets.
Bears say
Privia Health Group Inc faces significant challenges due to anticipated declines in Medicaid enrollment, with estimates reflecting an 8%-10% decrease by year-end as a result of re-determination activities following the conclusion of the public health emergency. This reduction in Medicaid membership is likely to impact the company's revenue streams and overall profitability, as the reliance on Medicaid support is an integral part of their business model. Furthermore, sustained declines in Medicaid operations, as indicated by guidance from operating partners, may lead to an erosion of market confidence and hinder growth prospects for Privia Health.
This aggregate rating is based on analysts' research of Privia Health Group and is not a guaranteed prediction by Public.com or investment advice.
PRVA Analyst Forecast & Price Prediction
Start investing in PRVA
Order type
Buy in
Order amount
Est. shares
0 shares